diosgenin has been researched along with Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Huang, W; Li, F; Li, S; Li, Y; Niu, H; Wan, C; Wang, Y; Wei, Z; Xin, G; Yu, X; Zhang, C; Zhang, K; Zhu, Y | 1 |
| Huang, W; Niu, H; Shen, Y; Shi, N; Wei, Z; Wen, L; Xia, Q; Xing, Z; Xiong, Q; Zeng, Z; Zhang, R | 1 |
2 other study(ies) available for diosgenin and Pancreatitis
| Article | Year |
|---|---|
Drug D, a Diosgenin Derive, Inhibits L-Arginine-Induced Acute Pancreatitis through Meditating GSDMD in the Endoplasmic Reticulum via the TXNIP/HIF-1α Pathway.
Topics: Acute Disease; Animals; Apoptosis; Arginine; Carrier Proteins; Diosgenin; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoribonucleases; Mice; Molecular Docking Simulation; Pancreatitis; Protein Serine-Threonine Kinases; Thioredoxins | 2022 |
Dihydrodiosgenin protects against experimental acute pancreatitis and associated lung injury through mitochondrial protection and PI3Kγ/Akt inhibition.
Topics: Acute Disease; Animals; Class Ib Phosphatidylinositol 3-Kinase; Diosgenin; Disease Models, Animal; Lung Injury; Male; Mice; Mice, Inbred BALB C; Mitochondria; Pancreatitis; Phosphoinositide-3 Kinase Inhibitors; Protective Agents; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar | 2018 |